Literature DB >> 813368

[The histological reaction of the endometrium to gestagens applied locally].

G Dallenbach-Hellweg, S Sievers.   

Abstract

To study the histologic changes produced by a new type of progesterone-medicated intrauterine device we examined the endometria of six hysterectomy specimens and one complete curettage. After being in place for 1 month the device induced a mild perifocal "arrested secretion" of the upper layers of the endometrium; after 3 months the change was pronounced, with decidually transformed stromal cells and atrophic glands. After 12 months these changes had partially progressed to fibrous atrophy. The endometrium underlying the perifocal-arrested secretion showed either proliferative or secretory changes almost like those of the lower functionalis of a normal menstrual cycle. A generalized atrophy of glands developed only when the patient had used oral contraceptive agents before the device was inserted. The perifocal arrested secretion thus differs from the generalized arrested secretion of the endometrium that follows use of oral or injected gestagens and from the decidualization produced mechanically by the local effect of an intrauterine device. The contraceptive effectiveness of the medicated intrauterine device, as compared with that of a simple device, is increased by the glandular atrophy of the arrested secretion. It avoids the dangers of the generalized effects of progestational agents by limiting the changes to the upper layers of the endometrium which are so important for implantation.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 813368     DOI: 10.1007/BF00432307

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histol        ISSN: 0340-1227


  12 in total

1.  EFFECT OF A PROGESTATIONAL AGENT ON ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL CANCER.

Authors:  W B WENTZ
Journal:  Obstet Gynecol       Date:  1964-09       Impact factor: 7.661

2.  The effect of intrauterine progesterone on the hypothalamic-hypophyseal-ovarian axis in humans.

Authors:  S A Tillson; M Marian; R Hudson; P Wong; B Pharriss; R Aznar; J Martinez-Manautou
Journal:  Contraception       Date:  1975-02       Impact factor: 3.375

3.  Progestasert: a uterine therapeutic system for long-term contraception: I. Philosophy and clinical efficacy.

Authors:  B B Pharriss; R Erickson; J Bashaw; S Hoff; V A Place; A Zaffaroni
Journal:  Fertil Steril       Date:  1974-11       Impact factor: 7.329

4.  Experience with the Dalkon Shield as a contraceptive device.

Authors:  J F Perlmutter
Journal:  Obstet Gynecol       Date:  1974-03       Impact factor: 7.661

5.  [Proceedings: Use of intrauterine pessaries].

Authors:  A A Haspels
Journal:  Arch Gynakol       Date:  1973-09-28

6.  Preliminary studies on the effect of hormone-releasing intrauterine devices.

Authors:  L L Doyle; T H Clewe
Journal:  Am J Obstet Gynecol       Date:  1968-06-15       Impact factor: 8.661

7.  Antifertility effects of intrauterine progesterone in the rabbit.

Authors:  B Seshadri; Y Gibor; A Scommegna
Journal:  Am J Obstet Gynecol       Date:  1971-02-15       Impact factor: 8.661

8.  Microdose intrauterine progestagen associated with intrauterine contraceptive devices.

Authors:  H W Horne; J M Scott; R H Underwood
Journal:  Int J Fertil       Date:  1970 Oct-Dec

9.  Intrauterine administration of progesterone by a slow releasing device.

Authors:  A Scommegna; G N Pandya; M Christ; A W Lee; M R Cohen
Journal:  Fertil Steril       Date:  1970-03       Impact factor: 7.329

10.  Clinical study of a progesterone-releasing intrauterine contraceptive device.

Authors:  P F Brenner; D L Cooper; D R Mishell
Journal:  Am J Obstet Gynecol       Date:  1975-03-01       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.